Search - tctmd.com

Displaying 621 - 640 of 1475

Sort: Relevancy | Date

Presentation TCT 2019

Case 3: A Patient With AF and ACS

Presenter: C. Michael Gibson

September 28, 2019

Presentation TCT 2019

Approaches to Reduce Bleeding Risk Post PCI in Patients Requiring OAC: Is There Any Role for ASA?

Presenter: C. Michael Gibson

September 28, 2019

Debate: Dual Therapy (OAC+SAPT) Should Be the Default Therapy at Discharge in Most Patients - Pro: Dual Therapy (OAC+SAPT) Should Be the Default Therapy at Discharge in Most Patients

Presentation TCT 2019

Pro: Dual Therapy (OAC+SAPT) Should Be the Default Therapy at Discharge in Most Patients

Presenter: C. Michael Gibson

September 27, 2019

Presentation TCT 2019

Impella-Assisted PCI: Can This Strategy Prevent AKI in High-Risk Patients?

Presenter: Michael Flaherty

September 27, 2019

Presentation TCT 2019

Getting Optimal Arterial and Venous Access for Large-Bore Catheter Procedures

Presenter: Michael Rinaldi

September 27, 2019

Presentation TCT 2019

Take Home for Clinicians

Presenter: C. Michael Gibson

September 26, 2019

Presentation TCT 2019

Don’t Forget About Your HDL: The AEGIS Program

Presenter: C. Michael Gibson

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

Presentation TCT 2019

Polymer-Free DES: Lessons Learned From Recent Trials

Presenter: Michael Maeng

September 26, 2019

Presentation TCT 2019

Current Practices and Best Approaches for Best Outcomes in the Cath Lab

Presenter: Michael Lim

September 26, 2019

Presentation TCT 2019

TCT 99: Outcomes with retrograde vs. antegrade chronic total occlusion revascularization

Presenter: Michael Megaly

September 25, 2019

Presentation TCT 2019

An Unforeseen Setback: Summary Level Meta-Analysis Brings Practice Back to the 1990s.

Presenter: Michael Jaff

September 25, 2019

News Industry News

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

September 25, 2019

News

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Michael O'Riordan

September 24, 2019

News Industry News

Angel Medical Systems Inc. Assembles World-Class Medical Advisory Board

September 20, 2019

News Daily News

Post-MI Mechanical Complications Infrequent but Deadly

Todd Neale

September 16, 2019

News Conference News ESC 2019

Transfer for Primary PCI Still Better Than Fibrinolysis After 16 Years: DANAMI-2

Todd Neale

September 04, 2019

News Conference News ESC 2019

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

Michael O'Riordan

September 03, 2019

News Conference News ESC 2019

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

Michael O'Riordan

September 01, 2019

News Conference News ESC 2019

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

Michael O'Riordan

September 01, 2019

Advertisement

Case 3: A Patient With AF and ACS

Approaches to Reduce Bleeding Risk Post PCI in Patients Requiring OAC: Is There Any Role for ASA?

Pro: Dual Therapy (OAC+SAPT) Should Be the Default Therapy at Discharge in Most Patients

Impella-Assisted PCI: Can This Strategy Prevent AKI in High-Risk Patients?

Getting Optimal Arterial and Venous Access for Large-Bore Catheter Procedures

Take Home for Clinicians

Don’t Forget About Your HDL: The AEGIS Program

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Polymer-Free DES: Lessons Learned From Recent Trials

Current Practices and Best Approaches for Best Outcomes in the Cath Lab

TCT 99: Outcomes with retrograde vs. antegrade chronic total occlusion revascularization

An Unforeseen Setback: Summary Level Meta-Analysis Brings Practice Back to the 1990s.

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Angel Medical Systems Inc. Assembles World-Class Medical Advisory Board

Post-MI Mechanical Complications Infrequent but Deadly

Transfer for Primary PCI Still Better Than Fibrinolysis After 16 Years: DANAMI-2

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content